Analysts Set Corteva, Inc. (NYSE:CTVA) PT at $56.00

Corteva, Inc. (NYSE:CTVAGet Rating) has earned an average recommendation of “Buy” from the sixteen analysts that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $56.00.

A number of brokerages have issued reports on CTVA. KeyCorp increased their target price on shares of Corteva from $58.00 to $63.00 and gave the company an “overweight” rating in a report on Tuesday, April 5th. Mizuho raised their price objective on Corteva from $55.00 to $60.00 in a research note on Friday, February 4th. Citigroup boosted their target price on Corteva from $59.00 to $66.00 and gave the stock a “buy” rating in a research report on Tuesday, March 22nd. Zacks Investment Research upgraded Corteva from a “sell” rating to a “hold” rating in a research report on Monday, February 7th. Finally, Redburn Partners upgraded shares of Corteva from a “neutral” rating to a “buy” rating in a research report on Monday, January 31st.

Shares of CTVA stock traded down $0.15 during midday trading on Friday, hitting $60.48. The company had a trading volume of 37,948 shares, compared to its average volume of 3,698,147. Corteva has a 52-week low of $40.60 and a 52-week high of $60.73. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.63 and a quick ratio of 1.08. The company’s 50 day simple moving average is $54.06 and its 200 day simple moving average is $48.78. The stock has a market cap of $43.96 billion, a price-to-earnings ratio of 25.49, a PEG ratio of 1.76 and a beta of 0.71.

Corteva (NYSE:CTVAGet Rating) last issued its quarterly earnings results on Wednesday, February 2nd. The company reported $0.08 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.08. The business had revenue of $3.48 billion for the quarter, compared to analyst estimates of $3.45 billion. Corteva had a net margin of 11.24% and a return on equity of 6.32%. The business’s revenue was up 8.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.04 earnings per share. Analysts anticipate that Corteva will post 2.48 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 15th. Investors of record on Tuesday, March 1st were issued a $0.14 dividend. The ex-dividend date of this dividend was Monday, February 28th. This represents a $0.56 annualized dividend and a yield of 0.93%. Corteva’s dividend payout ratio is currently 23.63%.

In other Corteva news, insider Brian Titus sold 23,500 shares of the company’s stock in a transaction dated Friday, February 11th. The shares were sold at an average price of $51.53, for a total value of $1,210,955.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Klaus A. Engel sold 3,000 shares of Corteva stock in a transaction dated Tuesday, March 15th. The stock was sold at an average price of $52.76, for a total value of $158,280.00. The disclosure for this sale can be found here. 0.08% of the stock is owned by corporate insiders.

Several institutional investors have recently modified their holdings of the company. Fruth Investment Management increased its holdings in shares of Corteva by 4.5% in the 1st quarter. Fruth Investment Management now owns 26,615 shares of the company’s stock valued at $1,529,000 after acquiring an additional 1,134 shares during the last quarter. Cooper Financial Group bought a new stake in Corteva during the first quarter valued at $220,000. Veriti Management LLC increased its stake in Corteva by 6.1% during the first quarter. Veriti Management LLC now owns 11,731 shares of the company’s stock valued at $674,000 after purchasing an additional 672 shares during the last quarter. Arden Trust Co lifted its position in shares of Corteva by 16.9% in the 1st quarter. Arden Trust Co now owns 11,372 shares of the company’s stock worth $654,000 after buying an additional 1,646 shares during the last quarter. Finally, Harbour Capital Advisors LLC acquired a new position in shares of Corteva in the 1st quarter valued at about $308,000. Institutional investors and hedge funds own 78.44% of the company’s stock.

Corteva Company Profile (Get Rating)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Featured Articles

Analyst Recommendations for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.